These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 19853950)

  • 1. Transarterial therapies in HCC: does embolization increase survival?
    Forner A; Trinchet JC
    J Hepatol; 2009 Dec; 51(6):981-3. PubMed ID: 19853950
    [No Abstract]   [Full Text] [Related]  

  • 2. Transarterial embolization for ruptured hepatocellular carcinoma: survival predictors.
    Toshikuni N; Takuma Y; Morimoto Y; Shimomura H; Yamamoto H
    Hepatogastroenterology; 2011; 58(106):565-9. PubMed ID: 21661432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma.
    Lau WY; Leow CK; Li AK
    Br J Hosp Med; 1997 Feb 5-18; 57(3):101-4. PubMed ID: 9196588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of adjuvant surgical therapy for continuous regional therapy for advanced hepatocellular carcinoma].
    Nakano H; Sasaki Y; Imaoka S; Furukawa H; Ishikawa O; Kabuto T; Kameyama M; Hiratsuka M; Ohigashi H; Nakamori S
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1490-2. PubMed ID: 7574740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma.
    Wu XZ; Xie GR; Chen D
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1178-82. PubMed ID: 17559361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenesis and selection of treatment modalities for hepatocellular carcinoma].
    Okamura J; Monden M; Sakon M; Mori T; Kuroda C; Sakurai M
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):203-9. PubMed ID: 3004362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoembolization and bland embolization: a critical appraisal.
    Befeler AS
    Clin Liver Dis; 2005 May; 9(2):287-300, vii. PubMed ID: 15831274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of liver resection with sequential transarterial chemoembolization in stage pT3 or pT4 hepatocellular carcinoma].
    Hasse F; Mehring UM; Castaneda F; Jäger H; Mathias KD; Löhlein D
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():208-10. PubMed ID: 9101833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
    J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transarterial embolization with microspheres in the treatment of monofocal HCC.
    Nicolini A; Fasani P; Manini MA; Martinetti L; Forzenigo LV; Iavarone M; Crespi S; Rossi G; Biondetti P; Colombo M; Sangiovanni A
    Dig Liver Dis; 2009 Feb; 41(2):143-9. PubMed ID: 18436490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regional therapy to prevent recurrence after surgery in hepatocellular carcinoma].
    Sasaki Y; Imaoka S; Masutani S; Ohashi I; Iwamoto S; Nakamori S; Ohigashi H; Kameyama M; Hiratsuka M; Ishikawa O
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1767-70. PubMed ID: 1326927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of preoperative transarterial chemoembolization on the prognosis for patients with resectable hepatocellular carcinoma: a meta-analysis of randomized trials.
    Wang X; Li J; Peng Y; Dai Y; Xu W
    Hepatogastroenterology; 2011; 58(107-108):869-74. PubMed ID: 21830407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma downstaging in liver transplantation.
    Yu CY; Ou HY; Huang TL; Chen TY; Tsang LL; Chen CL; Cheng YF
    Transplant Proc; 2012 Mar; 44(2):412-4. PubMed ID: 22410030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: a randomized phase III trial.
    Okusaka T; Kasugai H; Shioyama Y; Tanaka K; Kudo M; Saisho H; Osaki Y; Sata M; Fujiyama S; Kumada T; Sato K; Yamamoto S; Hinotsu S; Sato T
    J Hepatol; 2009 Dec; 51(6):1030-6. PubMed ID: 19864035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary abscess as a complication of transarterial embolization of multinodular hepatocellular carcinoma.
    Cubiella J; Sans M; Llovet JM; Bustamante J; Ferrer A; Caballeria J; Rodés J
    Am J Gastroenterol; 1997 Oct; 92(10):1942-3. PubMed ID: 9382078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hepatocellular carcinoma.
    Di Bisceglie AM
    Hepatology; 1991 Apr; 13(4):802-4. PubMed ID: 1849116
    [No Abstract]   [Full Text] [Related]  

  • 17. [Efficacy of transcatheter arterial infusion chemotherapy and transcatheter arterial embolization in 132 patients with primary hepatocellular carcinoma].
    Shi Z; Guo Y; Liu D
    Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):211-3. PubMed ID: 11776839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatocellular carcinoma: percutaneous ethanol injection/transarterial chemoembolization/radiofrequency thermoablation].
    Allgaier HP; Rossi S; Deibert P; Zuber I; Hering M; Blum HE
    Praxis (Bern 1994); 2000 Jun; 89(24):1056-60. PubMed ID: 10902462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of unresectable hepatocellular carcinoma.
    Vauthey JN; Marsh RW; Davis GL
    N Engl J Med; 1995 Sep; 333(13):877; author reply 878. PubMed ID: 7651489
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimal management of hepatocellular carcinoma: challenges and opportunities.
    Lin CL; Kao JH
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1336-8. PubMed ID: 20659219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.